Norene Norris-Walsh, MD
Obstetrics & Gynecology · Laguna Hills, CANPI 1952350225
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 41.0% of the total. Reporting peaked in 2019 at $151 and has fallen 94.8% since, to $8 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in CA, where the typical reported total is $387.
Across 26 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$183
- Ascend Therapeutics US, LLC$38
- Mayne Pharma Commercial LLC$36
- Exeltis, USA Inc.$33
- Bayer$31
- Therapeuticsmd, Inc.$27
- plus $98 from 6 others
What the payments were for
- Food & beverage$43297%
- Gifts$143%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $183 |
| Ascend Therapeutics US, LLC | 3 | $38 |
| Mayne Pharma Commercial LLC | 3 | $36 |
| Exeltis, USA Inc. | 2 | $33 |
| Bayer | 2 | $31 |
| Therapeuticsmd, Inc. | 2 | $27 |
| Baxter Healthcare | 1 | $26 |
| Olympus America Inc. | 1 | $20 |
| Merck | 1 | $16 |
| Coopersurgical, Inc. | 1 | $12 |
| Channel Medsystems, Inc. | 1 | $12 |
| Covidien LP | 1 | $12 |
How this compares
$446 in reported general payments places this provider in the 50th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 68 | $4,407 |
| Estradiol (Twice Weekly)Estradiol | 37 | $3,759 |
| ProgesteroneProgesterone, Micronized | 50 | $1,547 |
| ValacyclovirValacyclovir Hcl | 26 | $784 |
| Ibandronate Sodium | 11 | $487 |
| Terconazole | 11 | $311 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 18 | $286 |
| Alendronate Sodium | 23 | $192 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Laguna Hills
- Marc WinterLaguna Hills$399K
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.